1 Heimbach JK,Kuloik LM,Finn RS,et al.AASLD guidelines for the treatment of hepatocellular carcinoma[J].Hepatology,2018;67(1):358-380. 2 李诚,兰莉,杨超,等.2015-2017年哈尔滨市恶性肿瘤发病与死亡特征分析[J].实用肿瘤学杂志,2019,33(1):62-66. 3 Siegel RL,Miller KD,Jemal A,et al.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30. 4 Lozano R,Naghavi M,Foreman K,et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet,2012,380(9859):2095-2128. 5 Petrick JL,Kelly SP,Altekruse SF.Future of hepatocellular carcinoma incidence in the United States Forecast Through 2030[J].J Clin Oncol,2016,34(15):1787-1794. 6 Montagnoli A,Moll J,Colotta F.Targeting cell division cycle 7 kinase:a new approach for cancer therapy[J].Clin Cancer Res,2010,16(18):4503-4508. 7 Clarke LE,Fountaine TJ,Hennessy J,et al.Cdc7 expression in melanomas,Spitz tumors and melanocytic nevi[J].J Cutan Pathol,2009,36(4):433-438. 8 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. 9 Bonte D,Lindvall C,Liu H,et al.Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation[J].Neoplasia,2008,10(9):920-931. 10 Spurgers KB,Gold DL,Coombes KR,et al.Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression[J].J Biol Chem,2006,281(35):25134-25142. 11 Li X,Qian X,Jiang H,et al.Nuclear PGK1 alleviates ADP-dependent inhibition of CDC7 to promote DNA replication[J].Mol Cell,2018,72(4):650-660. 12 Jin S,Ma H,Yang W,et al.Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1[J].J Mol Med(Berl),2018,96(6):513-525. 13 Labib K.How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells?[J].Genes Dev,2010,24(12):1208-1219. |